• Product NameTranilast
• Brief DescriptionInhibitors
• Purification99.50%
• Biological ActivityTranilast is an antiallergic drug by inhibiting lipid mediator and cytokine release from inflammatory cells, used for the treatment of allergic disorders such as asthma, allergic rhinitis and atopic dermatitis.
• Target NameOthers inhibitor
• CAS No. 53902-12-8
• Calculated MW 327.33
• Formulation C18H17NO5
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Other
  SMILES:COC1=C(C=C(C=C1)/C=C/C(=O)NC2=CC=CC=C2C(=O)O)OC
  Pathways:Others
  Receptor:Others
  Boling pt:
  Melting pt:166.2-168.2C
  Solubility:DMSO: 66 mg/mL (201.63 mM)
  Appearance:White Powder
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Suzawa H, et al. Jpn J Pharmacol, 1992, 60(2), 91-96.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting